Douglas Giordano was a senior vice president in Pfizer’s Worldwide Business Development Group. Before joining Pfizer’s Worldwide Business Development group in 2007, he held positions of increasing responsibility within Pfizer’s U.S. Pharmaceuticals commercial strategy and business development team. Before his U.S. pharmaceuticals operating role, Mr. Giordano worked in a mergers and acquisitions role within Pfizer’s Medical Technology Group. Prior to his role with the Medical Technology Group, he held positions within Pfizer’s U.S. Pharmaceutical Group in finance and global manufacturing. Prior to joining Pfizer, he was a consultant at Booz, Allen & Hamilton. He currently serves on the Board of Directors of ICU Medical and Viiv Healthcare.
Mr. Giordano earned a bachelor’s degree in biomedical engineering from Duke University and an M.B.A. from Cornell University’s Johnson School of Business.